This article was originally published in The Tan Sheet
Executive SummaryIdentical bills to establish public education awareness programs on emergency contraception introduced in Senate, House March 6. "Emergency Contraception Education Act" (S 1990) would provide $10 mil. per year for five years for the CDC and Health Resources & Services Administration to develop and disseminate consumer, healthcare professional information describing "use, safety, efficacy and availability" of ECs. Introduced by Sen. Patty Murray (D-Wash.), the bill was referred to the Health & Education Committee. Its twin in the House was introduced by Rep. Louise Slaughter (D-N.Y.); HR 3887 was referred to the Commerce Committee. Bills come one week after Rep. Melissa Hart (R-Penn.) introduced a measure that would bar federal education funding for schools that provide access to ECs; HR 3805 was referred to the Education Committee...
You may also be interested in...
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.
Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.